ConductScience.org, home

Paper3754487

Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA scission.

Harker WG and 4 others. Cancer Res, 1986. Cited by 87 papers, by iCite.

Cite this record

ConductScience Library. Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA scission. Papers, record 3754487. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3754487

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA scission.
PubMed
Journal
Cancer Res
PubMed
Year
1986
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
87
iCite
Relative citation ratio, by iCite
2.94
iCite
Revised in PubMed
2013-11-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Harker WGW G
2Bauer DD
3Etiz BBB B
4Newman RAR A
5Sikic BIB I

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DoxorubicinMajor topic
Sarcoma, ExperimentalMajor topic
VerapamilMajor topic
Animals
Antineoplastic Agents
Cell Line
Cell Survival
Drug Resistance
Drug Synergism
Female
Humans
Uterine Neoplasms
Vinblastine

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA 33303NCI NIH HHSUnited StatesP01CA033303PubMed and NIHNIH RePORTER
CA-0777NCI NIH HHSUnited StatesK04CA000777PubMed and NIHNIH RePORTER
GM-07065NIGMS NIH HHSUnited StatesPubMedPubMed

Download CSV of grants

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.

PMIDTitleJournalYearIn PapersSource
39991087Metabolomic Analysis, Antiproliferative, Anti-Migratory, and Anti-Invasive Potential of Amlodipine in Lung Cancer Cells.Drug Des Devel Ther2025https://conductscience.org/library/papers/39991087PubMed
30374303Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy.Front Pharmacol2018https://conductscience.org/library/papers/30374303PubMed
28276667Sulindac sulfide selectively increases sensitivity of ABCC1 expressing tumor cells to doxorubicin and glutathione depletion.J Biomed Res2016https://conductscience.org/library/papers/28276667PubMed
26456750Novel delivery approaches for cancer therapeutics.J Control Release2015https://conductscience.org/library/papers/26456750PubMed
26009590Oestrogen enhances cardiotoxicity induced by Sunitinib by regulation of drug transport and metabolism.Cardiovasc Res2015https://conductscience.org/library/papers/26009590PubMed
8398588R-verapamil: pharmacokinetics and effects on PR interval, blood pressure and heart rate.Br J Clin Pharmacol1993https://conductscience.org/library/papers/8398588PubMed
8004760Effect of mitomycin C, verapamil, and hyperthermia on human gastric adenocarcinoma.Cancer Chemother Pharmacol1994https://conductscience.org/library/papers/8004760PubMed
7765325Pharmacologic circumvention of multidrug resistance.Cytotechnology1993https://conductscience.org/library/papers/7765325PubMed
7512899Anthracycline antibiotics in cancer therapy. Focus on drug resistance.Drugs1994https://conductscience.org/library/papers/7512899PubMed
3179186Modulation in vitro and in vivo of cytotoxicity but not cellular levels of doxorubicin by the calmodulin inhibitor trifluoperazine is dependent on the level of resistance.Br J Cancer1988https://conductscience.org/library/papers/3179186PubMed
3165724Correction of altered plasma membrane potentials. A possible mechanism of cyclosporin A and verapamil reversal of pleiotropic drug resistance in neoplasia.Cancer Chemother Pharmacol1988https://conductscience.org/library/papers/3165724PubMed
2789934Changes in cellular glutathione content during adriamycin treatment in human ovarian cancer--a possible indicator of chemosensitivity.Br J Cancer1989https://conductscience.org/library/papers/2789934PubMed
2598402Relationship between cytotoxicity, drug accumulation, DNA damage and repair of human ovarian cancer cells treated with doxorubicin: modulation by the tiapamil analog RO11-2933.Cancer Chemother Pharmacol1989https://conductscience.org/library/papers/2598402PubMed
2569325Effect of calcium antagonists on the chemosensitivity of two multidrug-resistant human tumour cell lines which do not overexpress P-glycoprotein.Br J Cancer1989https://conductscience.org/library/papers/2569325PubMed
2548560A simple outpatient treatment with oral ifosfamide and oral etoposide for patients with small cell lung cancer (SCLC).Br J Cancer1989https://conductscience.org/library/papers/2548560PubMed
2450775Enhancement of the cytogenetic efficacy of the antitumor agent bleomycin by the calcium and calmodulin antagonist fendiline.Experientia1988https://conductscience.org/library/papers/2450775PubMed
2060546Effects of verapamil enantiomers and major metabolites on the cytotoxicity of vincristine and daunomycin in human lymphoma cell lines.Eur J Clin Pharmacol1991https://conductscience.org/library/papers/2060546PubMed
1976451Mitomycin C cross-resistance induced by adriamycin in human ovarian cancer cells in vitro.Cancer Chemother Pharmacol1990https://conductscience.org/library/papers/1976451PubMed
1680368Modulation of vinblastine sensitivity by dipyridamole in multidrug resistant fibrosarcoma cells lacking mdr1 expression.Br J Cancer1991https://conductscience.org/library/papers/1680368PubMed
1671830Modulation of mitomycin C-induced multidrug resistance in vitro.Cancer Chemother Pharmacol1991https://conductscience.org/library/papers/1671830PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TOP2A7153PubTator's text mininghttps://conductscience.org/library/genes/7153

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3754487

GET https://conductscience.org/api/papers/v1/3754487/authors